✦ LIBER ✦

N of 1 randomized trials for investigating new drugs

✍ Scribed by Gordon H. Guyatt; Arend Heyting; Roman Jaeschke; Jana Keller; Jonathan D. Adachi; Robin S. Roberts

Book ID: 113296998
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 762 KB
Volume: 11
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(90)90003-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Demonstrating drug safety: Clinical usef

Demonstrating drug safety: Clinical usefulness of N-of 1 randomized controlled trials

✍ knowles, Sandra R; Neilson, Heather; Weber, Elizabeth A; Shear, Neil H 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Information Needed for Clinical Trials o

Information Needed for Clinical Trials of New Drugs.

✍ Cooper, John A. D. 📂 Article 📅 1966 🏛 American Chemical Society ⚖ 497 KB

Systematic review of randomized trials o

Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome

✍ Lise L. Gluud; Kurt Christensen; Erik Christensen; Aleksander Krag 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Vasoconstrictor drugs may improve renal function in hepatorenal syndrome (HRS), but the effect on mortality has not been established. We therefore performed a systematic review of randomized trials on vasoconstrictor drugs for type 1 or type 2 HRS. Mortality was the primary outcome measure. Eligible

N-of-1 Trials: A New Future?

✍ Eric B. Larson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Seizure-Free Outcome in Randomized Add-o

Seizure-Free Outcome in Randomized Add-on Trials of the New Antiepileptic Drugs

✍ Deana M. Gazzola; Laura J. Balcer; Jacqueline A. French 📂 Article 📅 2007 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 65 KB

Expanded clinical trials of treatments f

Expanded clinical trials of treatments for multiple sclerosis: Copolymer 1 (COP-1) treatment investigational new drug (IND) program

✍ Yafit Stark 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views